Navigation Links
RSC New England Clinicians to Present at RESOLVE New England’s 20th Annual Conference on November 2nd, 2013
Date:10/31/2013

Lexington, MA (PRWEB) October 31, 2013

The 20th Annual RESOLVE New England Conference on Fertility Treatment, Donor Choices and Adoption will feature three clinicians from the Reproductive Science Center of New England. Samuel Pang, MD, Kristen Wright, MD, and Adele Kauffman, PhD will discuss important topics of interest on fertility to both patients and clinicians alike. This conference is being held on Saturday November 2nd from 8am-5pm at the Best Western Royal Plaza Hotel, Marlborough, MA.

Dr. Samuel Pang will lead a session entitled Diminished Ovarian Reserve: What It Means and Treatment Options. This session will focus on how female fertility decreases with age, the impact age can have on the quality of eggs and a healthy pregnancy, and the options women have available to either preserve fertility when they are young or alternatives to using their own eggs if that is not an option. In addition, Dr. Pang will also conduct a session on LGBT Family Formation.

Dr. Kristen Wright will present a session entitled, When Treatment Isn’t Working, dur which she will discuss how fertility treatment plans should be continuously monitored and adjusted over time if there is not a resulting pregnancy. The issue of when to seek a second opinion will also be addressed.

Dr. Adele Kauffman will co-present a session on Surrogacy and Donor: Psychological Aspects and Disclosure. This workshop discusses the emotional and ethical issues for men and women, secrecy vs. privacy and deciding how and when to talk with a child and others about donor egg, donor sperm and surrogacy.

The Keynote address, On being ‘normal’, will be given by Elizabeth Jordan Carr, the first baby born through in-vitro fertilization in 1981.

Pre-registration is preferred, and financial scholarships are available from RESOLVE to cover half or all of the cost to attend. Also, CEU credits are available for clinical personnel.

Reproductive Science Center of New England helps people achieve healthy pregnancies by providing the most advanced fertility solutions and exceptional patient care. RSCNE is proud to be a nationally recognized Top 10 Fertility Treatment Center and our award-winning physicians and Center of Excellence distinctions ensure patients will receive the highest quality care and best outcomes throughout your journey to parenthood. With 11 convenient locations across New England and a proven record of success, RSCNE is dedicated to helping couples realize their family dreams.

Since 1974, RESOLVE New England has been the leading voice and progressive driving force connecting the New England community on the many paths to parenthood.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11285523.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Population Genetics Assigns Asymmetric Adaptor Library Construction Patent To New England Biolabs
2. New England Biolabs supports iGEM synthetic biology competition
3. New England Biolabs Releases the NEBNext Microbiome DNA Enrichment Kit
4. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
5. New England Biolabs opens seventh subsidiary in Singapore
6. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
7. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
8. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
9. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
10. New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
11. New England Biolabs Develops Novel Polymerase with Ultra-High Fidelity and Minimal GC Bias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
Breaking Biology News(10 mins):